Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
iiM, LLC, also known as Innovation in Motion, is an early-stage investment firm founded in 2013 and headquartered in Merriam, Kansas. The firm focuses on identifying, funding, and curating early-stage companies innovating in agriculture, animal health, and human health sectors. iiM aims to support entrepreneurs addressing global challenges, particularly as the world population approaches 10 billion by 2050.
As of 2023, iiM manages a portfolio of 30 companies, with a strategic approach to providing both capital and expertise to startups. The firm operates as a managed syndicate of accredited investor members, allowing for collaborative investment opportunities. iiM has a notable presence in the Kansas City startup ecosystem and is actively involved in various initiatives to promote innovation in its focus sectors.
iiM's investment strategy emphasizes sustainability and health, aligning with global trends and challenges. The firm has established a reputation for its commitment to supporting early-stage companies that contribute to these critical areas. Their portfolio reflects a diverse range of innovative solutions aimed at improving health outcomes and agricultural practices.
iiM, LLC primarily invests at the Seed and Series A stages in companies located in the United States and Canada. The firm concentrates on sectors including agriculture, animal health, and human health. Their investment strategy is designed to provide both capital and expertise to startups that align with their thesis of addressing global challenges.
Investment checks typically range from $150,000 to $300,000, with the potential for larger investments as the syndicate grows. iiM has indicated a target of increasing check sizes to $500,000 or more. The firm actively seeks companies that are innovating in precision agriculture, animal health diagnostics, and medical devices, while explicitly avoiding human pharmaceuticals due to their capital intensity.
iiM's approach includes cross-vertical pattern matching, where technologies developed for human health may be adapted for animal health applications. This strategy allows iiM to leverage insights and innovations across its focus sectors, enhancing the potential for impactful investments.
iiM, LLC has a diverse portfolio of 30 companies, showcasing its commitment to innovation in agriculture, animal health, and human health. Notable portfolio companies include:
Lydia Kinkade: Managing Director at iiM, LLC. Lydia leads sourcing, diligence, portfolio management, and investor relations. She is actively involved in the Kansas City startup ecosystem and has a background in health innovation.
R. Lee Harris: CEO of Cohen-Esrey, LLC, and Managing Member of iiM. He brings extensive experience in real estate and investment management.
Jeanette Jayne: Managing Director and Executive Vice President at Cohen-Esrey, LLC. Jeanette has a strong background in investment strategy and portfolio management.
Bob Esrey: Chairman of Cohen-Esrey, LLC. Bob has significant experience in real estate and investment sectors.
Lee Borck: Chairman of Innovative Livestock Services, Inc. Lee has expertise in livestock management and agricultural investments.
Dr. Kelly Lechtenberg: Founder and President of Midwest Veterinary Services. Dr. Lechtenberg specializes in veterinary medicine and animal health.
Lamar Eby: Senior Executive in Business and Leadership Development. Lamar has a background in business strategy and leadership.
Dr. Blake Williamson: Founder of Healthcare Innovations Consulting Group. Dr. Williamson has expertise in healthcare innovation and consulting.
Mike McRoberts: Angel Investor with experience in early-stage investments.
Jason Rawlings: CEO of Focus Workforces, bringing expertise in workforce management.
Amanda (Curtis) Burkardt: CEO and Founder of Nutripeutics; iiM Consulting Director with a focus on health innovation.
Rick Kahle: Entrepreneur with experience in various sectors.
Jon Ferguson: Former Commercial Farm Operator with insights into agricultural practices.
Cisse Spragins, Ph.D: Founder, Owner & CEO of Rockwell Labs Ltd., specializing in agricultural solutions.
Dana Hauck: Partner at Innovative Livestock Services, Inc., with expertise in livestock management.
David Morris: Former CEO of Premium Nutritional Products, bringing experience in nutrition and health.
Daniel E. Walker, Ph.D: Serial Entrepreneur with a focus on health and technology.
Chuck Mackey: President of Capital Management, Inc., with a background in finance and investment.
Dr. James R. McAtee: Managing Partner at Orthopaedic & Sports Medicine Center, specializing in orthopedic health.
Dr. Harriet S. Langely: Nephrologist at Midwest Nephrology Consultants, with expertise in kidney health.
Robert Kirkland: Founding Partner at Kirkland Woods & Martinsen LLP, specializing in legal services for businesses.
Dr. Michael Perry: Assistant Professor of Orthopedic Surgery and Sports Medicine, contributing expertise in medical education.
Philip N. Krause: Founding Member at Krause Law LLC, providing legal counsel for startups.
Crissa (Seymour) Cook: Partner at Hovey Williams, specializing in intellectual property law.
Nicholas Hense: Principal at iiM, contributing to investment strategy and portfolio management.
To pitch iiM, LLC, founders should reach out via email to Lydia Kinkade at lkinkade@iimkc.com. It is advisable to include a comprehensive pitch deck that outlines the business model, market analysis, and financial projections. iiM prefers pitches that clearly demonstrate how the startup aligns with their investment thesis in agriculture, animal health, and human health.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory. iiM values clarity and conciseness in pitches, so founders should aim to present their ideas succinctly while covering all critical aspects.
In 2023, iiM, LLC continued to expand its portfolio, actively investing in innovative startups within its focus sectors. The firm has been recognized among the top venture capital firms in Kansas City, highlighting its commitment to supporting early-stage companies.
iiM has also published various editions of its newsletter, 'The Innovator,' from 2019 to 2023, providing insights into early-stage investment trends and portfolio updates. This newsletter serves as a resource for entrepreneurs and investors alike, showcasing iiM's active role in the startup ecosystem.
What are iiM's investment criteria?
iiM focuses on early-stage companies in agriculture, animal health, and human health sectors. They primarily invest at the Seed and Series A stages, targeting innovative solutions that address global challenges.
How can I apply or pitch to iiM?
Founders can pitch their startups by contacting Lydia Kinkade at lkinkade@iimkc.com. It is recommended to include a detailed business plan and financial projections in the pitch.
What makes iiM different from other investors?
iiM combines capital investment with strategic guidance and industry expertise, particularly in agriculture and health sectors. Their focus on sustainability and addressing global challenges sets them apart.
What is iiM's geographic scope?
iiM primarily invests in companies located in the United States and Canada, focusing on sectors that contribute to health and sustainability.
What is the typical check size for investments?
iiM typically invests between $150,000 and $300,000 per company, with plans to increase check sizes to $500,000 or more as their syndicate grows.
What is iiM's post-investment involvement?
iiM actively participates in the growth of its portfolio companies by providing follow-on capital, strategic guidance, and access to a network of professionals in relevant sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.